NewsJanuary 18, 2010RFL Presents “Value of Genetic Testing” to Carefirst Blue CrossResults for Life and ACLA recently briefed officials at Carefirst Blue Cross and Blue Shield in Baltimore on the value and importance of genetic testing. The session outlined the science underlying genomics and genetic testing, as well as the importance of such tests in improving diagnosis and care for a range of conditions, including birth defects, adult leukemia, heart disease and breast cancer. Representing RFL were Sherri Bale, Co-Founder, Gene Dx; Vicky Pratt, Chief Director, Molecular Genetics, Quest Diagnostics; Kaye Jones, Director, Corporate Coding Resources, LabCorp; and David Mongillo, Vice President for Policy and Medical Affairs, ACLA.To view the slides, click here.
|
|
2010 Copyright American Clinical Laboratory Association 1100 New York Avenue, NW, Suite 725 West, Washington, DC 20005 - (P): 202-637-9466 Email: info@labresultsforlife.org - Terms and Conditions |